Abstract
The glycosylation of biomolecules is essential for cell recognition and immune regulation. Intermolecular carbohydrate-carbohydrate interactions between the antibody Fc fragment and Fc receptor (FcR) are required for immune-cell activation. Further, antibody Fc glycans can be glycoengineered to enhance these interactions for applications in cancer immunotherapy: e.g. the removal of core fucose in the antibody Fc glycan enhances binding of the Fc fragment to the FcR and, thereby, immune-cell activity.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
